Dr. Fening has overseen more than $10M in translational research programs and supported more than 60 translational projects over the last decade. He co-leads the I-Corps@NCATS Cleveland site and sits on the board of directors for the I-Corps@Ohio program. He also is founding executive faculty for the Cleveland NeuroDesign Fellowship, an advisor to the Cleveland CTSA, and a frequent advisor to the LabToMarket C3i program. Dr. Fening is a co-founder of two companies including as Chief Technology Officer of Apto Orthopaedics Corporation, an early stage company focusing on non-invasive methods to adjust orthopaedic implants. He also serves or has served on the board of directors for several for- and not-for-profits.

Prior to joining Case Western Reserve University, Dr. Fening was the Director of Orthopaedic Devices at the Austen BioInnovation Institute in Akron and the Director of Orthopaedic Research for Summa Health Systems. Prior to that, he was the Director of Research for Cleveland Clinic Sports Health. His areas of research focus included the biomechanics of sports injuries to the knee, shoulder and head and in innovation more broadly across orthopaedic devices. He has received over $20M in grant funding, published more than 100 peer reviewed publications and presentations, and has several patents. He was a 2017 recipient of the Crain's Cleveland Business Forty Under 40, and is a member of several national and international professional societies.